U.S. Senator Tina Smith’s Bipartisan Legislation to Combat Lyme Disease and Other Tick-Borne Illnesses Passes the Senate Unanimously

Most recent data shows Minnesota saw 3,551 cases in 2024 alone WASHINGTON, D.C. – U.S. Senator Tina Smith announced the bipartisan Kay Hagan Tick Reauthorization Act passed the Senate unanimously. The bill will expand research, testing and treatment for Lyme and other tick-borne diseases. “Minnesota is proud to have more than 10,000 lakes and thousands of rivers for us to enjoy, and we’re always especially eager to get outside after a long winter,” said Sen. Smith. “Unfortunately, the number of Lyme disease cases in the state—and states across the country—is on the rise. This bill would step up regional efforts at researching, testing and treating Lyme and other tick-borne diseases. We must cut down on tick-borne illnesses and for the sake of Americans’ health and well-being, we need to keep moving this bill forward.” The bill, co-led by Sen. Susan Collins (R-ME), was named in honor of former Sen. Kay Hagan (D-NC), who passed away on October 28, 2019, due to complications from the tick-borne disease Powassan virus. Over the past two decades, Minnesota has experienced a significant rise in tick-borne diseases. According to the Minnesota Department of Health, Lyme disease remains the state’s most commonly reported tick-borne illness, with 3,551 probable cases reported in 2024. In the same year, Minnesota also reported hundreds of cases of other tickborne diseases: 627 cases of anaplasmosis, 89 cases of babesiosis and 14 cases of Powassan virus disease. Using a three-pronged approach, The Kay Hagan Tick Act will: Continue implementation and updates of the Department of Health and Human Services’ National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People. This would support ongoing federal efforts to advance research, improve diagnostics, and strengthen coordination on vector-borne diseases. Reauthorize the Regional Centers of Excellence in Vector-Borne Disease for five years. These centers support critical research, surveillance and public health efforts to address tick-borne diseases and other vector-borne threats. Reauthorize CDC grants to state health departments to strengthen vector-borne disease prevention and response efforts. These grants would support surveillance, early detection and diagnosis, treatment efforts, public education, and partnerships to address Lyme disease and other vector-borne diseases. ###